BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32523628)

  • 41. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study.
    Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S
    BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
    Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
    Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
    Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
    Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.
    Smith I; Kahaleh M
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):31-5. PubMed ID: 25160753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durability of Endoscopic Treatment for Dysplastic Barrett's Esophagus.
    Reed CC; Shaheen NJ
    Curr Treat Options Gastroenterol; 2019 Jun; 17(2):171-186. PubMed ID: 31077058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic management of dysplasia and early oesophageal cancer.
    Zeki SS; Bergman JJ; Dunn JM
    Best Pract Res Clin Gastroenterol; 2018; 36-37():27-36. PubMed ID: 30551853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
    N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times.
    Hamade N; Sharma P
    Curr Gastroenterol Rep; 2017 Aug; 19(10):48. PubMed ID: 28819902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
    Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
    Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases.
    Muñoz-Largacha JA; Litle VR
    J Vis Surg; 2017; 3():128. PubMed ID: 29078688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
    Pech O
    Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Puricelli WP; Nishioka NS
    Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Buried Barrett's Esophagus with High-Grade Dysplasia after Radiofrequency Ablation.
    Castela J; Serrano M; Ferro SM; Pereira DV; Chaves P; Pereira AD
    Clin Endosc; 2019 May; 52(3):269-272. PubMed ID: 30300980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-radical, stepwise complete endoscopic resection of Barrett's epithelium in short segment Barrett's esophagus has a low stricture rate.
    Koutsoumpas A; Wang LM; Bailey AA; Gillies R; Marshall R; Booth M; Sgromo B; Maynard N; Braden B
    Endosc Int Open; 2016 Dec; 4(12):E1292-E1297. PubMed ID: 27995191
    [No Abstract]   [Full Text] [Related]  

  • 55. Post-ablation surveillance in Barrett's esophagus: A review of the literature.
    Stier MW; Konda VJ; Hart J; Waxman I
    World J Gastroenterol; 2016 May; 22(17):4297-306. PubMed ID: 27158198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Krishnadath KK; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):359-69. PubMed ID: 18494131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoscopic applications of cryospray ablation therapy-from Barrett's esophagus and beyond.
    Sreenarasimhaiah J
    World J Gastrointest Endosc; 2016 Aug; 8(16):546-52. PubMed ID: 27621766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Canto MI; Shaheen NJ; Almario JA; Voltaggio L; Montgomery E; Lightdale CJ
    Gastrointest Endosc; 2018 Sep; 88(3):438-446.e2. PubMed ID: 29626424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case.
    Allende D; Dumot J; Yerian L
    Dis Esophagus; 2013 Apr; 26(3):314-8. PubMed ID: 23009180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus.
    Cholapranee A; Trindade AJ
    Curr Treat Options Gastroenterol; 2019 Mar; 17(1):32-47. PubMed ID: 30663018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.